当前位置:首页 - 行情中心 - 国药股份(600511) - 财务分析 - 现金流量表

国药股份

(600511)

  

流通市值:159.92亿  总市值:218.05亿
流通股本:5.53亿   总股本:7.55亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金11,974,375,550.6656,483,077,866.2739,821,987,410.3125,805,029,245.77
  收到的税费返还4,378.49666,271.29588,977.41588,977.41
  收到其他与经营活动有关的现金153,374,814.3841,752,743.23368,254,545.51296,098,385.5
  经营活动现金流入小计12,127,754,743.4557,325,496,880.7940,190,830,933.2326,101,716,608.68
  购买商品、接受劳务支付的现金14,500,335,656.4951,550,999,642.439,468,754,090.5326,061,155,569.16
  支付给职工以及为职工支付的现金236,106,843.75854,542,592.38626,161,020.19425,224,768.79
  支付的各项税费419,149,061.641,771,229,006.981,128,095,920.77803,866,224.99
  支付其他与经营活动有关的现金565,113,976.971,143,208,126.971,018,252,683.85321,904,882.54
  经营活动现金流出小计15,720,705,538.8555,319,979,368.7342,241,263,715.3427,612,151,445.48
  经营活动产生的现金流量净额-3,592,950,795.42,005,517,512.06-2,050,432,782.11-1,510,434,836.8
二、投资活动产生的现金流量:
  收回投资收到的现金3,094,248.8718,329,499.933,139,870.643,139,870.64
  取得投资收益收到的现金-32,273,886.7829,327,149.229,327,149.2
  处置固定资产、无形资产和其他长期资产收回的现金净额5,107.2202,302.2578,328.6335,280
  投资活动现金流入小计3,099,356.0750,805,688.9632,545,348.4732,502,299.84
  购建固定资产、无形资产和其他长期资产支付的现金6,420,132.868,194,378.1740,419,863.9420,579,477.2
  投资活动现金流出小计6,420,132.868,194,378.1740,419,863.9420,579,477.2
  投资活动产生的现金流量净额-3,320,776.73-17,388,689.21-7,874,515.4711,922,822.64
三、筹资活动产生的现金流量:
  取得借款收到的现金106,000,000319,447,721.2319,447,721.2160,000,000
  筹资活动现金流入小计106,000,000319,447,721.2319,447,721.2160,000,000
  偿还债务支付的现金148,363,906.68923,448,321.92636,348,932.49435,834,964.5
  分配股利、利润或偿付利息支付的现金4,892,203.06653,281,757.75644,787,849.53618,447,171.44
  其中:子公司支付给少数股东的股利、利润-27,543,689.5124,433,001.583,920,214.07
  支付其他与筹资活动有关的现金39,408,192.35130,194,249.04114,391,693.1877,442,297.71
  筹资活动现金流出小计192,664,302.091,706,924,328.711,395,528,475.21,131,724,433.65
  筹资活动产生的现金流量净额-86,664,302.09-1,387,476,607.51-1,076,080,754-971,724,433.65
五、现金及现金等价物净增加额-3,682,935,874.22600,652,215.34-3,134,388,051.58-2,470,236,447.81
  加:期初现金及现金等价物余额8,892,046,272.38,291,394,056.968,291,394,056.968,291,394,056.96
  期末现金及现金等价物余额5,209,110,398.088,892,046,272.35,157,006,005.385,821,157,609.15
补充资料:
  净利润-2,089,403,586-991,483,406.86
  资产减值准备-5,563,843.29-8,207,322.15
  固定资产和投资性房地产折旧-73,297,846.2-35,900,835.86
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-73,297,846.2-35,900,835.86
  无形资产摊销-54,366,923.24-27,273,148.39
  长期待摊费用摊销-10,067,575.5-5,648,711.51
  处置固定资产、无形资产和其他长期资产的损失--212,185.96--548.56
  固定资产报废损失-102,985.11-102,830.57
  公允价值变动损失--66,164.34--
  财务费用-27,165,852.32-14,966,586.59
  投资损失--585,314,905.57--293,601,361.38
  递延所得税--20,566,368.53--16,264,245.5
  其中:递延所得税资产减少--14,177,873.67--12,065,726.92
    递延所得税负债增加--6,388,494.86--4,198,518.58
  存货的减少--240,873,051.48--349,381,141.6
  经营性应收项目的减少--692,570,321.85--2,066,194,870.11
  经营性应付项目的增加-1,140,496,132.06-17,549,011.2
  其他---2,888,532.64
  现金的期末余额-8,892,046,272.3-5,821,157,609.15
  减:现金的期初余额-8,291,394,056.96-8,291,394,056.96
  现金及现金等价物的净增加额-600,652,215.34--2,470,236,447.81
公告日期2026-04-232026-03-202025-10-222025-08-21
审计意见(境内)标准无保留意见
TOP↑